what was the first glp 1 agonist Comparing Ozempic, Wegovy and Other GLP-1 Drugs Timeline of GLP-1 discovery and
Description
Discover how allulose and GLP-1 may work together for blood glucose control and weight management

Regulatory submission for retatrutide is expected in 2026

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

A large global retrospective cohort study (n=331,863 matched patients

This product does not contain synthetic GLP-1 and is not a GLP-1 agonist drug
